{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T14:26:37Z","timestamp":1793456797229,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T00:00:00Z","timestamp":1552348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005036","name":"Universitetet i Bergen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005036","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010586","name":"Haukeland\u00a0Universitetssjukehus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.jcyt.2019.03.001","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T14:47:51Z","timestamp":1553698071000},"page":"468-482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Translation of a standardized manufacturing protocol for mesenchymal stromal cells: A systematic comparison of validation and manufacturing data"],"prefix":"10.1016","volume":"21","author":[{"given":"MARKUS THOMAS","family":"ROJEWSKI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RAMIN","family":"LOTFI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CECILIE","family":"GJERDE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KAMAL","family":"MUSTAFA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ELENA","family":"VERONESI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AYMEN B.","family":"AHMED","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARKUS","family":"WIESNETH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SIXTEN","family":"K\u00d6RPER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LUC","family":"SENSEB\u00c9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PIERRE","family":"LAYROLLE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00d8LVE","family":"HELLEM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HUBERT","family":"SCHREZENMEIER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9419","key":"10.1016\/j.jcyt.2019.03.001_bib0001","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"Le Blanc","year":"2004","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jcyt.2019.03.001_bib0002","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1016\/j.leukres.2009.05.023","article-title":"Third-party mesenchymal stem cells as part of the management of graft-failure after haploidentical stem cell transplantation","volume":"33","author":"von Bonin","year":"2009","journal-title":"Leuk Res"},{"issue":"1","key":"10.1016\/j.jcyt.2019.03.001_bib0003","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13287-017-0541-2","article-title":"Autologous bone marrow-derived cell transplantation in decompensated alcoholic liver disease: what is the impact on liver histology and gene expression patterns?","volume":"8","author":"Lanthier","year":"2017","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"10.1016\/j.jcyt.2019.03.001_bib0004","doi-asserted-by":"crossref","first-page":"847","DOI":"10.5966\/sctm.2015-0245","article-title":"Adipose Mesenchymal Stromal Cell-Based Therapy for Severe Osteoarthritis of the Knee: A Phase I Dose-Escalation Trial","volume":"5","author":"Pers","year":"2016","journal-title":"Stem Cells Transl Med"},{"issue":"2","key":"10.1016\/j.jcyt.2019.03.001_bib0005","first-page":"341","article-title":"Cranial reconstruction using allogeneic mesenchymal stromal cells: a phase 1 first-in-human trial. Tissue engineering. Part C","volume":"12","author":"Morrison","year":"2017","journal-title":"Methods"},{"issue":"2","key":"10.1016\/j.jcyt.2019.03.001_bib0006","first-page":"83","article-title":"Bone regeneration strategies with bone marrow stromal cells in orthopaedic surgery","volume":"64","author":"Stanovici","year":"2016","journal-title":"Curr Res Transl Med"},{"issue":"1","key":"10.1016\/j.jcyt.2019.03.001_bib0007","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40729-017-0084-4","article-title":"Autogenous bone grafts in oral implantology-is it still a \u201cgold standard\u201d? A consecutive review of 279 patients with 456 clinical procedures","volume":"3","author":"Sakkas","year":"2017","journal-title":"Int J Implant Dent"},{"issue":"2","key":"10.1016\/j.jcyt.2019.03.001_bib0008","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bjoms.2005.04.015","article-title":"Morbidity at the iliac crest donor site following bone grafting of the cleft alveolus","volume":"44","author":"Swan","year":"2006","journal-title":"Br J Oral Maxillofac Surg Title"},{"issue":"1","key":"10.1016\/j.jcyt.2019.03.001_bib0009","doi-asserted-by":"crossref","first-page":"10","DOI":"10.13004\/kjnt.2014.10.1.10","article-title":"Resorption of Autogenous Bone Graft in Cranioplasty: Resorption and Reintegration Failure","volume":"10","author":"Lee","year":"2014","journal-title":"Korean J Neurotrauma"},{"issue":"4","key":"10.1016\/j.jcyt.2019.03.001_bib0010","first-page":"1169","article-title":"Completely resorption of autologous skull flap after orthotopic transplantation: a case report","volume":"7","author":"Yin","year":"2014","journal-title":"J Clin Exp Med"},{"issue":"3","key":"10.1016\/j.jcyt.2019.03.001_bib0011","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.stem.2008.07.003","article-title":"A perivascular origin for mesenchymal stem cells in multiple human organs","volume":"3","author":"Crisan","year":"2008","journal-title":"Cell stem cell"},{"issue":"8","key":"10.1016\/j.jcyt.2019.03.001_bib0012","doi-asserted-by":"crossref","first-page":"e43255","DOI":"10.1371\/journal.pone.0043255","article-title":"GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC","volume":"7","author":"Fekete","year":"2012","journal-title":"PloS one"},{"issue":"11","key":"10.1016\/j.jcyt.2019.03.001_bib0013","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.3727\/096368912X657990","article-title":"GMP-compliant isolation and expansion of bone marrow-derived MSCs in the closed, automated device quantum cell expansion system","volume":"22","author":"Rojewski","year":"2013","journal-title":"Cell Transplant"},{"issue":"2","key":"10.1016\/j.jcyt.2019.03.001_bib0014","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jcyt.2014.04.002","article-title":"Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications","volume":"17","author":"Wuchter","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2019.03.001_bib0015","article-title":"Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric, non-comparative trial","author":"Gomez-Barrena","year":"2018","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.jcyt.2019.03.001_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195891","article-title":"Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I\/II safety and feasibility study","volume":"13","author":"Fern\u00e1ndez","year":"2018","journal-title":"PloS one"},{"issue":"1","key":"10.1016\/j.jcyt.2019.03.001_bib0017","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhep.2017.03.001","article-title":"Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I\u2013II, open-label, clinical study","volume":"67","author":"Detry","year":"2017","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jcyt.2019.03.001_bib0018","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/annrheumdis-2015-208918","article-title":"Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib\/IIa clinical trial","volume":"76","author":"Alvaro-Gracia","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.jcyt.2019.03.001_bib0019","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12967-016-0998-2","article-title":"Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I\/II)","volume":"14","author":"Lamo-Espinosa","year":"2016","journal-title":"J Transl Med"},{"issue":"8","key":"10.1016\/j.jcyt.2019.03.001_bib0020","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1097\/TP.0000000000000678","article-title":"Treatment of Knee Osteoarthritis With Allogeneic Bone Marrow Mesenchymal Stem Cells: A Randomized Controlled Trial","volume":"99","author":"Vega","year":"2015","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.jcyt.2019.03.001_bib0021","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbmt.2013.11.033","article-title":"Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients","volume":"20","author":"Introna","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jcyt.2019.03.001_bib0022","first-page":"121","article-title":"Regulation (EC) No 1394\/2007 of the European Parliament and of the Council of 13 November2007 on advanced therapy medicinal products and amending Directive 2001\/ 83\/EC and Regulation (EC) No 726\/2004","volume":"50","year":"2007","journal-title":"Official Journal of the European Union"},{"issue":"5","key":"10.1016\/j.jcyt.2019.03.001_bib0023","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/scrt504","article-title":"Pre-clinical studies of bone regeneration with human bone marrow stromal cells and biphasic calcium phosphate","volume":"5","author":"Brennan","year":"2014","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"10.1016\/j.jcyt.2019.03.001_bib0024","first-page":"239","article-title":"Transportation conditions for prompt use ofex vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal\/stem cells for bone regeneration. Tissue engineering. Part C","volume":"20","author":"Veronesi","year":"2014","journal-title":"Methods"},{"issue":"4","key":"10.1016\/j.jcyt.2019.03.001_bib0025","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"5","key":"10.1016\/j.jcyt.2019.03.001_bib0026","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/14653240500319234","article-title":"Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement","volume":"7","author":"Horwitz","year":"2005","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.jcyt.2019.03.001_bib0027","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/j.jcyt.2016.03.248","article-title":"Minimal criteria of expanded mesenchymal stem cells for clinical application: Hypothesis and experiments","volume":"18","author":"Pharm","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2019.03.001_bib0028","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1055\/s-0041-102960","article-title":"Flow Cytometry Control of MSC used as ATMP for Clinical Trials (Durchflusszytometrische Kontrolle von MSC-Produkten im Rahmen der Herstellung als ATMP f\u00fcr klinische Pr\u00fcfungen)","volume":"5","author":"Rojewski","year":"2015","journal-title":"Transfusionsmedizin"},{"issue":"2","key":"10.1016\/j.jcyt.2019.03.001_bib0029","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cryobiol.2014.07.005","article-title":"Frozen adipose-derived mesenchymal stem cells maintain high capability to grow and differentiate","volume":"69","author":"Minonzio","year":"2014","journal-title":"Cryobiology"},{"issue":"2","key":"10.1016\/j.jcyt.2019.03.001_bib0030","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cryobiol.2015.07.003","article-title":"Mesenchymal stromal cells derived from various tissues: Biological, clinical and cryopreservation aspects","volume":"71","author":"Marquez-Curtis","year":"2015","journal-title":"Cryobiology"},{"issue":"1","key":"10.1016\/j.jcyt.2019.03.001_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cryobiol.2014.10.011","article-title":"Morphology, cell viability, karyotype, expression of surface markers and plasticity of three human primary cell line cultures before and after the cryostorage in LN2 and GN2","volume":"70","author":"Del Pino","year":"2015","journal-title":"Cryobiology"},{"key":"10.1016\/j.jcyt.2019.03.001_bib0032","doi-asserted-by":"crossref","DOI":"10.1038\/srep26463","article-title":"Cryopreserved mesenchymal stromal cells maintain potency in a retinal ischemia\/reperfusion injury model: Toward an off-the-shelf Therapy","volume":"6","author":"Gramlich","year":"2016","journal-title":"Scientific reports"},{"issue":"8","key":"10.1016\/j.jcyt.2019.03.001_bib0033","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1089\/scd.2015.0329","article-title":"Effects of freeze-thawing and intravenous infusion on mesenchymal stromal cell gene expression","volume":"25","author":"Hoogduijn","year":"2016","journal-title":"Stem Cells Dev"},{"issue":"2","key":"10.1016\/j.jcyt.2019.03.001_bib0034","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/humrep\/den441","article-title":"Are stem cells inherently more prone to cryopreservation-induced apoptosis compared to ordinary somatic cells?","volume":"24","author":"Heng","year":"2009","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.jcyt.2019.03.001_bib0035","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cryobiol.2010.10.160","article-title":"Response of the cell membrane-cytoskeleton complex to osmotic and freeze\/thaw stresses","volume":"61","author":"Ragoonanan","year":"2010","journal-title":"Cryobiology"},{"issue":"1","key":"10.1016\/j.jcyt.2019.03.001_bib0036","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jcyt.2012.10.002","article-title":"The mesenchymal stromal cells dilemma\u2013does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?","volume":"15","author":"Galipeau","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2019.03.001_bib0037","first-page":"48","article-title":"Directive 2004\/23\/EC of the European Parliament and of the Council of 31 March 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells","volume":"47","year":"2004","journal-title":"Official Journal of the European Union"},{"key":"10.1016\/j.jcyt.2019.03.001_bib0038","first-page":"40","article-title":"Commission Directive 2006\/17\/EC of 8 February 2006 implementing Directive 2004\/23\/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells","volume":"49","year":"2006","journal-title":"Official Journal of the European Union"},{"issue":"5","key":"10.1016\/j.jcyt.2019.03.001_bib0039","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3109\/14653249.2012.655420","volume":"14","author":"Fekete","year":"2012","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.jcyt.2019.03.001_bib0040","first-page":"129","article-title":"Essential components for ex vivo proliferation of mesenchymal stromal cells. Tissue engineering. Part C","volume":"20","author":"Fekete","year":"2014","journal-title":"Methods"},{"issue":"8","key":"10.1016\/j.jcyt.2019.03.001_bib0041","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/ng.405","article-title":"Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II","volume":"41","author":"Schwarz","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jcyt.2019.03.001_bib0042","series-title":"Europ\u00e4isches Arzneibuch","year":"2014"},{"issue":"1","key":"10.1016\/j.jcyt.2019.03.001_bib0043","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000357096","article-title":"A single-tube real-time PCR assay for Mycoplasma detection as a routine quality control of cell therapeutics","volume":"41","author":"Janetzko","year":"2014","journal-title":"Transfusion medicine and hemotherapy: offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie"},{"key":"10.1016\/j.jcyt.2019.03.001_bib0044","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00103-014-2089-y","article-title":"Qualit\u00e4tssicherung in der humangenetischen Diagnostik","volume":"58","author":"Stuhrmann-Spangenberg","year":"2015","journal-title":"Bundesgesundheitsbl"},{"key":"10.1016\/j.jcyt.2019.03.001_bib0045","first-page":"281","article-title":"Leitlinien und Stellungnahmen. Deutsche Gesellschaft f\u00fcr Humangenetik e.V. (GfH), Berufsverband Deutscher Humangenetiker e.V. (BVDH): S2-Leitlinie Humangenetische Diagnostik","volume":"23","author":"Stuhrmann-Spangenberg","year":"2011","journal-title":"Med Genet"},{"key":"10.1016\/j.jcyt.2019.03.001_bib0046","article-title":"General Guidelines and Quality Assurance for Cytogenetics. A common European framework for quality assessment for constitutional, acquired and molecular cytogenetic investigations. E.C.A. Permanent Working Group for Cytogenetics and Society","volume":"29","author":"Hastings","year":"2012","journal-title":"ECA Newsletter"},{"key":"10.1016\/j.jcyt.2019.03.001_bib0047","first-page":"11","article-title":"Specific Constitutional Cytogenetic Guidelines. A common European framework for quality assessment for constitutional, acquired and molecular cytogenetic investigations. E.C.A. Permanent Working Group for Cytogenetics and Society","volume":"30","author":"Hastings","year":"2012","journal-title":"ECA Newsletter"},{"issue":"1","key":"10.1016\/j.jcyt.2019.03.001_bib0048","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13287-018-0951-9","article-title":"Cell therapy induced regeneration of severely atrophied mandibular bone in a clinical trial","volume":"9","author":"Gjerde","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2019.03.001_bib0049","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6025918","article-title":"A Multicentric, Open-Label, Randomized, Comparative Clinical Trial of Two Different Doses of Expanded hBM-MSCs Plus Biomaterial versus Iliac Crest Autograft, for Bone Healing in Nonunions after Long Bone Fractures: Study Protocol","volume":"2018","author":"Gomez-Barrena","year":"2018","journal-title":"Stem Cells Int"},{"issue":"1","key":"10.1016\/j.jcyt.2019.03.001_bib0050","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/14653240903313958","article-title":"The clonogenic potential of hematopoietic stem cells and mesenchymal stromal cells in various hematologic diseases: a pilot study","volume":"12","author":"Kurt Yuksel","year":"2010","journal-title":"Cytotherapy"},{"issue":"8","key":"10.1016\/j.jcyt.2019.03.001_bib0051","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1537-2995.2007.01219.x","article-title":"Two steps to functional mesenchymal stromal cells for clinical application","volume":"47","author":"Bartmann","year":"2007","journal-title":"Transfusion"},{"issue":"8","key":"10.1016\/j.jcyt.2019.03.001_bib0052","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/j.1537-2995.2007.01220.x","article-title":"Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells","volume":"47","author":"Schallmoser","year":"2007","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.jcyt.2019.03.001_bib0053","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1089\/107632702320934001","article-title":"Replicative aging and gene expression in long-term cultures of human bone marrow stromal cells","volume":"8","author":"Banfi","year":"2002","journal-title":"Tissue engineering"},{"issue":"12","key":"10.1016\/j.jcyt.2019.03.001_bib0054","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115963","article-title":"Impact of aging on the regenerative properties of bone marrow-, muscle-, and adipose-derived mesenchymal stem\/stromal cells","volume":"9","author":"Beane","year":"2014","journal-title":"PloS one"},{"issue":"1 Suppl","key":"10.1016\/j.jcyt.2019.03.001_bib0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3233\/BME-140973","article-title":"Donor's age dependent proliferation decrease of human bone marrow mesenchymal stem cells is linked to diminished clonogenicity","volume":"24","author":"Li","year":"2014","journal-title":"Bio-medical materials and engineering"},{"issue":"4","key":"10.1016\/j.jcyt.2019.03.001_bib0056","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3892\/ijmm.2016.2489","article-title":"Effect of the harvest procedure and tissue site on the osteogenic function of and gene expression in human mesenchymal stem cells","volume":"37","author":"Henrich","year":"2016","journal-title":"Int J Mol Med"},{"issue":"5","key":"10.1016\/j.jcyt.2019.03.001_bib0057","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00266-014-0372-9","article-title":"Comparison of cell number, viability, phenotypic profile, clonogenic, and proliferative potential of adipose-derived stem cell populations between centrifuged and noncentrifuged fat","volume":"38","author":"Ibatici","year":"2014","journal-title":"Aesthetic Plast Surg"},{"issue":"1","key":"10.1016\/j.jcyt.2019.03.001_bib0058","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.stem.2011.12.005","article-title":"Limited acquisition of chromosomal aberrations in human adult mesenchymal stromal cells","volume":"10","author":"Sensebe","year":"2012","journal-title":"Cell stem cell"},{"issue":"7","key":"10.1016\/j.jcyt.2019.03.001_bib0059","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jcyt.2013.03.005","article-title":"Risk of tumorigenicity in mesenchymal stromal cell-based therapies\u2013bridging scientific observations and regulatory viewpoints","volume":"15","author":"Barkholt","year":"2013","journal-title":"Cytotherapy"},{"issue":"8","key":"10.1016\/j.jcyt.2019.03.001_bib0060","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood-2009-05-219907","article-title":"Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation","volume":"115","author":"Tarte","year":"2010","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.jcyt.2019.03.001_bib0061","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1158\/0008-5472.CAN-08-4630","article-title":"Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation","volume":"69","author":"Rosland","year":"2009","journal-title":"Cancer research"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324919300374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324919300374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:37:56Z","timestamp":1761442676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324919300374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1465324919300374"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2019.03.001","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Translation of a standardized manufacturing protocol for mesenchymal stromal cells: A systematic comparison of validation and manufacturing data","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2019.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society for Cell and Gene Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}